News & Analysis on Clinical Trial Services & Contract Research And Development
A patient-controlled injector and a prefilled pen for patients with hand dexterity issues were among the drug delivery technologies celebrated at PharmaPack Europe’s awards this year.
The US State Patent and Trademark Office has granted Teewinot Life Science Corporation its second patent this year covering biosynthetic cannabinoid production methods.
ERT has launched a Phase I QT Center of Excellence to enable pharmaceutical companies to make better informed “go/no-go” drug development decisions.
Feature
Experts from Syneos Health and UDG Healthcare comment on the current state of the global pharma contract sales market – which is estimated to reach $9.48bn by 2023.